story of the week
Bamlanivimab Plus Etesevimab in Mild or Moderate COVID-19
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Bamlanivimab Plus Etesevimab in Mild or Moderate Covid-19
N. Engl. J. Med 2021 Jul 14;[EPub Ahead of Print], M Dougan, A Nirula, M Azizad, B Mocherla, RL Gottlieb, P Chen, C Hebert, R Perry, J Boscia, B Heller, J Morris, C Crystal, A Igbinadolor, G Huhn, J Cardona, I Shawa, P Kumar, AC Adams, J Van Naarden, KL Custer, M Durante, G Oakley, AE Schade, TR Holzer, PJ Ebert, RE Higgs, NL Kallewaard, J Sabo, DR Patel, MC Dabora, P Klekotka, L Shen, DM SkovronskyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.